Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-HT1A receptor is a G protein-coupled receptor primarily located in the central nervous system, particularly in the cortex, hippocampus, septum, amygdala, and raphe nuclei. It functions as both an autoreceptor on serotonergic neurons, inhibiting serotonin release, and as a postsynaptic receptor, mediating inhibitory neurotransmission. Activation of this receptor influences mood regulation, anxiety control, cognition, learning/memory processes, and induces the secretion of various hormones. Dysregulation of 5-HT1A receptor function is implicated in psychiatric conditions, including depression and anxiety disorders, making it a key target for antidepressant and anxiolytic medications.
Agonists or antagonists that modulate receptor activity, leading to downstream effects on neuronal excitability and neurotransmitter release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine 1A receptor (5-HT1A).